![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2249|181|1|65-75
ISSN: 0009-9104
Source: CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.1, 2015-07, pp. : 65-75
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab in the Treatment of Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis
Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis
Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis
Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab in ANCA-Associated Vasculitis: Fad or Fact?
Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. :